Leukocyte counting during process control of leukoreduced blood components
Related Experiment Video
Updated: Oct 13, 2026
Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
1Blood Transfusion Service, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Background And Objectives:
To describe the characteristics of counting assays used for process control of leukoreduction.
Materials And Methods:
Literature review.
Results:
Counting assays with good performance characteristics are an essential element of the process control of leukoreduction. A recent multicenter study by a Working Party of the ISBT has evaluated three widely used methods for counting low numbers of leukocytes in leukoreduced blood.
Conclusion:
Automated methods provide greater accuracy and better inter-laboratory precision than Nageotte hematocytometry. However, deterioration of performance as a result of prolonged sample shipment remains an obstacle to centralized testing services. Although several mathematical approaches have been used to model the distribution of residual leukocytes in leukoreduced blood, no single model has been shown to be clearly superior.
Related Concept Videos
01:21Structure and Function of Leukocytes
White blood cells protect the body...
01:27Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...